Background: Norway recently changed national policies in psychiatry emphasizing the right for persons with psychosis to choose medication-free treatment. Long-term anti-psychotic medication is debated, in terms of effectiveness and side effects. New guidelines generate increased treatment options for patients with severe mental illness. Methods: This study explore users’ experiences with treatment choices in this unique context. We interviewed eleven patients diagnosed with psychosis about their experiences of choosing treatment, analysing the transcribed data team based and stepwise. Results: Findings show how choosing treatment appears to be a complicated process with many influencing factors. Emerging themes were about the dialogue between patient and therapist, the importance of having a treatment choice, difficulties choosing the unknown not knowing what helps, choice influenced by the level of experience with in particular medication, and coercive measures contrasting the freedom of choice. Conclusion: The freedom to choose was perceived important, but the complexity of choosing showed how optimal care might not always equal the freedom to choose. Aiming for optimal care, we need to consider how involuntary admission and other coercive measures are used, and possibly improved, in order to care without further traumatizing people who are already in extreme distress. Ethical approval: The Regional Ethics Committee for Medical Health Research (REK southeast 2017/736) defined this study as health service research and hence according to the Norwegian health research legislation, the study was to be approved by the local data protection officer. The data protection officer for Health Bergen approved the study in July 2017 (2017/8692).